# The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment

> **NCT00544791** · PHASE2 · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Mild Cognitive Impairment (MCI)

## Interventions

- **DRUG:** melatonin
- **DRUG:** placebo like melatonin tablets

## Key facts

- **NCT ID:** NCT00544791
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-10
- **Primary completion:** —
- **Final completion:** 2010-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2007-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00544791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00544791, "The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00544791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*